X4 Pharmaceuticals

XFOR

Börsenwert 333 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	23,5 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	20,8 Mio. $	–	–	–
3	3 BlackRock New York	12,1 Mio. $	+295.243 $	+10.612	+4 %
4	4 Vanguard Group Malvern, Pennsylvania	10,9 Mio. $	-167.987 $	-6.038	-2 %
5	5 OrbiMed New York	9,9 Mio. $	–	–	–
6	6 Soleus Capital Management Greenwich, Connecticut	6,37 Mio. $	+4,25 Mio. $	+152.664	Neu
7	7 Adage Capital Partners Boston, Massachusetts	5,94 Mio. $	–	–	–
8	8 Sio Capital Management New York	4,99 Mio. $	–	–	–
9	9 Perceptive Advisors New York	4,93 Mio. $	–	–	–
10	KCM 10 Kingdon Capital Management New York	4,83 Mio. $	–	–	–
11	11 Axa Paris, France	4,27 Mio. $	+779 $	+28	+0 %
12	12 Geode Capital Management Boston, Massachusetts	4,09 Mio. $	+132.598 $	+4.766	+5 %
13	13 State Street Boston, Massachusetts	3,51 Mio. $	+88.834 $	+3.193	+4 %
14	14 Ensign Peak Advisors Salt Lake City, Utah	3,39 Mio. $	+2,26 Mio. $	+81.181	Neu
15	15 Avidity Partners Management Dallas, Texas	3,35 Mio. $	+2,24 Mio. $	+80.433	Neu
16	16 Morgan Stanley New York	1,95 Mio. $	+932.079 $	+33.502	+250 %
17	17 UBS O'Connor Chicago, Illinois	1,86 Mio. $	-377.929 $	-13.584	-23 %
18	18 Goldman Sachs New York	1,47 Mio. $	+914.552 $	+32.872	+1.355 %
19	19 Northern Trust Chicago, Illinois	1,47 Mio. $	-7.874 $	-283	-0,8 %
20	20 Schonfeld Strategic Advisors New York	1,27 Mio. $	+339.145 $	+12.190	+67 %
21	21 Parkman Healthcare Partners Stamford, Connecticut	1,12 Mio. $	+35.250 $	+1.267	+5 %
22	22 Citadel Advisors Miami, Florida	1,06 Mio. $	-895.132 $	-32.174	-56 %
23	23 Point72 Asset Management Stamford, Connecticut	903.500 $	–	–	–
24	24 Propel Bio Management Los Angeles, California	743.650 $	–	–	–
25	25 Susquehanna International Group Bala Cynwyd, Pennsylvania	698.704 $	+92.507 $	+3.325	+25 %

X4 Pharmaceuticals XFOR Börsenwert 333 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 333 Mio. $